Filter
1255
Filtered Results: 1255
Text search:
U.S.
Food
and
Drug
Administration
Featured
Recommendations
119
New Publications
349
Language
Document type
No document type
737
Studies & Reports
191
Guidelines
186
Manuals
65
Strategic & Response Plan
37
Fact sheets
14
Training Material
12
Situation Updates
6
Brochures
2
Resource Platforms
2
Videos
2
Infographics
1
Countries / Regions
India
61
Global
42
Kenya
38
Ethiopia
36
Nigeria
32
Tanzania
29
South Africa
27
Uganda
27
Sierra Leone
24
Western and Central Europe
24
Liberia
24
Philippines
22
Myanmar / Burma
21
Rwanda
19
Zambia
18
Ghana
16
USA
12
Latin America and the Carribbean
12
Nepal
11
Cambodia
11
Bangladesh
11
Indonesia
11
Lesotho
9
Malawi
9
Eastern Europe
9
Russia
9
South Sudan
9
Africa
8
Congo, Democratic Republic of
8
Botswana
8
Colombia
7
Ukraine
7
Zimbabwe
7
Germany
7
West and Central Africa
7
Namibia
7
Middle East and North Africa
6
Syria
5
Mozambique
5
Haiti
5
Eastern Europe and Central Asia
5
Brazil
5
Thailand
4
Cameroon
4
Laos
4
South–East Asia Region
4
East and Southern Africa
4
Sudan
4
Eswatini/ Swaziland
4
Peru
3
Venezuela
3
Jordan
3
Paraguay
3
Argentina
3
Tajikistan
2
Senegal
2
Asia
2
Western Pacific Region
2
Vietnam
2
Sri Lanka
2
Central African Republic
2
Angola
2
Iraq
2
Somalia
2
Switzerland
1
Mexico
1
El Salvador
1
Turkey
1
Benin
1
Iran
1
Singapore
1
Afghanistan
1
Qatar
1
Guinea
1
Guinea-Bissau
1
Lithuania
1
Turkmenistan
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Papua New Guinea
1
Yemen
1
Palestine
1
Mali
1
Libya
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
488
Clinical Guidelines
136
Public Health
59
Key Resources
40
Women & Child Health
38
Pharmacy & Technologies
18
Capacity Building
12
Toolboxes
Mental Health
107
TB
95
HIV
90
AMR
89
COVID-19
86
Pharmacy
60
NTDs
48
Rapid Response
34
Ebola & Marburg
33
Caregiver
29
NCDs
26
Planetary Health
23
Refugee
18
Specific Hazards
13
Conflict
13
Disability
11
Zika
8
Global Health Education
8
Cholera
7
Natural Hazards
6
Health Financing Toolbox
5
Social Ethics
4
Polio
4
In 1964 medical mission was challenged and called to define its distinctiveness and its special role in the context of that particular time. The consultation "Tuebingen I" clearly stated: "The Christian church has a specific task in the field of health and healing"1, and developed a conce...
Options for the decontamination and reuse of respirators in the context of the COVID-19 pandemic
recommended
Guiding principles for reuse are:
Respirators which have been visibly contaminated (e.g. during procedure at intubated patients, such as suction cleaning of airways, taking probes, extubation attempts, etc.) or are damaged or not fitting, should be discarded and cannot be taken for re-use or de...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
UNAIDS 2016 / Meeting Report
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
This technical package represents a select group of strategies based on the best available evidence to help communities and states sharpen their focus on prevention activities with the greatest potential to prevent suicide
